youtube_live
Q2 2027 earnings
See resultschevron_right
BALAXI:NSE
Balaxi Pharmaceuticals Ltd
₹23.50
arrow_downward
-1.43%(-0.34) 1D
Nov 13, 3:30:00 PM GMT+5:30 · INR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for BALAXI...
Open
₹23.99
High
₹23.99
Low
₹22.50
Mkt. cap
1.28B
Avg. vol.
22.08K
Volume
14.07K
P/E ratio
53.15
52-wk high
₹40.98
52-wk low
₹15.20
EPS
₹0.44
No. of employees
500
Open
₹23.99
High
₹23.99
Low
₹22.50
Mkt. cap
1.28B
Avg. vol.
22.08K
Volume
14.07K
P/E ratio
53.15
52-wk high
₹40.98
52-wk low
₹15.20
EPS
₹0.44
No. of employees
500
News stories
From web sources and news partners
Big News Network.com
·
1 day ago
Balaxi Pharmaceuticals Q2 FY27 Revenue Rises 45 percentage, EBITDA Surges 338 percentage and PAT Grows 450 percentage YoY
www.marketscreener.com
·
2 days ago
Balaxi Pharmaceuticals Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2026
About Balaxi Pharmaceuticals Ltd
CEO-
Employees500
Founded1942
Headquarters-
SectorHealth Care
IndustryHealth care provider
Websitebalaxipharma.in